Most of these genes are reported to be involved in either lymphoid development (such as PAX5 and IKZF1), lymphoid signaling, cell cycle and apoptosis regulation (mostly tumor suppressors such as CDKN2A), DNA repair, therapy response, or transcription factors [30,31]. Here, CDKN2A is linked to neoplasm.